Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$23,659,704
+$20,261,628 QoQ
Shares Held
150,968
+578.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#107
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 5%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $304,795,936 across 15 Drug Manufacturers - General names. NVS ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,429 | $80,876,372 | |
| 2 | JNJ |
Johnson & Johnson
|
265,777 | $67,499,384 | |
| 3 | ABBV |
AbbVie Inc.
|
205,994 | $51,836,330 | |
| 4 | MRK |
Merck & Co., Inc.
|
220,270 | $28,304,695 | |
| 5 | NVS |
Novartis AG
This page
|
150,968 | $23,659,704 | |
| 6 | AMGN |
Amgen Inc
|
40,234 | $14,569,536 | |
| 7 | PFE |
Pfizer Inc
|
423,589 | $10,200,023 | |
| 8 | AZN |
Astrazeneca PLC
|
35,321 | $6,697,568 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,659,704 | 150,968 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,398,076 | 22,246 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,754,918 | 19,982 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,090,824 | 16,304 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $1,829,550 | 15,119 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $1,271,429 | 11,405 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $1,107,582 | 11,382 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,307,892 | 11,371 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $581,590 | 5,463 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $523,019 | 5,407 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $757,577 | 7,503 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $383,502 | 3,765 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $413,428 | 4,097 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $325,496 | 3,538 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $322,872 | 3,559 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $256,464 | 3,034 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $249,034 | 2,838 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $250,339 | 2,862 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $207,394 | 2,536 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $251,183 | 2,753 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $253,875 | 2,970 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $283,290 | 3,000 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $260,271 | 2,993 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $277,042 | 3,172 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $228,221 | 2,768 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||